Nose-to-brain drug delivery by HS15 micelles for brain targeting of insoluble drug
Agomelatine (AGO) is an antidepressant with limited clinical application due to its low bioavailability caused by poor water solubility, severe hepatic degradation, and poor intracerebral distribution. Nanotechnology-based strategies constitute a powerful tool by utilizing drug solubility and target...
Saved in:
| Main Authors: | Wei Zhang, Long Wan, Meiqi Han, Wen Guo, Zhiqi Wang, Xinyue Zhang, Xuyang Liu, Jiahao Wang, Yuling Mao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Compuscript Ltd
2024-04-01
|
| Series: | Acta Materia Medica |
| Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2023-0051 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancements in Nanocarrier Systems for Nose-to-Brain Drug Delivery
by: Thi-Thao-Linh Nguyen, et al.
Published: (2025-04-01) -
Nose-to-brain drug delivery: from bench to bedside
by: Isabell Drath, et al.
Published: (2025-05-01) -
A tailored phytosomes based nose-to-brain drug delivery strategy: Silver bullet for Alzheimer's disease
by: Xiao Yue, et al.
Published: (2025-02-01) -
Overcoming the Blood-Brain Barrier for Drug Delivery to the Brain
by: Jennifer S. Katz, et al.
Published: (2025-07-01) -
Brain-targeting Nanoparticle Drug Delivery Systems for Brain Tumors
by: Yi Zhao, et al.
Published: (2025-01-01)